LINC00869: A Protein Targeted for Neurodegenerative Diseases (G57234)

Target Name: LINC00869

NCBI ID: G57234

LINC00869

Other Name(s): FAM91A2 | Long intergenic non-protein coding RNA 869, transcript variant 1 | LINC00869 variant 1 | long intergenic non-protein coding RNA 869

LINC00869: A Protein Targeted for Neurodegenerative Diseases

LINC00869 (FAM91A2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the FAM (FAM1A2) family of proteins, which are known for their role in intracellular signaling. LINC00869 has been shown to play a role in the regulation of cellular processes that are important for brain development and function, such as cell survival, proliferation, and migration.

One of the unique features of LINC00869 is its ability to interact with several different protein partners, including c-Jun, a transcription factor that is involved in the regulation of many cellular processes. This interaction between LINC00869 and c-Jun has been shown to play a role in the regulation of cellular processes that are important for brain development and function, such as the regulation of neuronal survival and the development of neurodegenerative diseases.

Another interesting feature of LINC00869 is its ability to interact with the protein p16INK4a. This interaction between LINC00869 and p16INK4a has been shown to play a role in the regulation of cellular processes that are important for cancer progression and the development of neurofibromatosis, a disease characterized by the formation of fiber-like structures in the brain.

In addition to its role in intracellular signaling, LINC00869 has also been shown to play a role in the regulation of cellular processes that are important for the development and function of tissues. For example, LINC00869 has been shown to play a role in the regulation of the development and differentiation of neural tissues, as well as the regulation of the growth and migration of these tissues.

Given the unique combination of features that LINC00869 has, it is a promising drug target. Researchers are currently working to develop compounds that can inhibit the activity of LINC00869 and its downstream targets, in order to treat a variety of neurodegenerative diseases. For example, LINC00869 has been shown to play a role in the regulation of the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. By targeting LINC00869 and its downstream targets, researchers hope to develop new treatments that can slow the progression of these diseases and improve the quality of life for patients.

Protein Name: Long Intergenic Non-protein Coding RNA 869

The "LINC00869 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00869 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets